What is AngioDynamics, Inc.'s current stock price?

AngioDynamics, Inc. (ANGO) currently trades at USD 10.31. Track real-time price changes and historical performance on AllInvestView.

What sector is AngioDynamics, Inc. in?

AngioDynamics, Inc. operates in the Health Care sector. AllInvestView lets you analyze sector allocation across your entire portfolio.

AngioDynamics, Inc.

🧾 Earnings Recap – Q3 2026

AngioDynamics delivered another strong quarter, demonstrating sustained top-line growth and expanding profitability driven by robust performance in Med Tech and thrombectomy portfolios. The company continues to execute on strategic priorities, raising full-year guidance for the third consecutive quarter.

Med Tech segment, led by Auryon, achieved 19th consecutive quarter of double-digit YoY growth, supported by international expansion post-CE Mark.
Thrombectomy portfolio (AlphaVac and AngioVac) grew approximately 18% YoY, with AlphaVac showing record sequential revenue increase and positive clinical adoption.
NanoKnife saw notable growth in disposables and capital, with expanded European indications and a favorable CMS CPT 1 code rollout bolstering market access.
The company reaffirmed its strategic focus on large, high-margin markets amid macro uncertainties, leveraging innovation and clinical milestones.
Full-year revenue and EBITDA guidance were raised for the third straight quarter, reflecting confidence in continued profitable growth.

View full recap page

AngioDynamics, Inc. Analysis (ANGO)

United States Health Care Official Website Stock

Is AngioDynamics, Inc. a good investment? AngioDynamics, Inc. (ANGO) is currently trading at 10.31 USD. Market analysts have a consensus price target of 19.33 USD. This suggests a potential upside from current levels.

Earnings Schedule: AngioDynamics, Inc. is expected to release its next earnings report on July 21, 2026. The market consensus estimate for Forward EPS is -0.11.

Investor FAQ

Does AngioDynamics, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is AngioDynamics, Inc.?

AngioDynamics, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be July 21, 2026. The company currently has a trailing EPS of -0.76.

Company Profile

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company's thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit for use in extracorporeal circulatory support procedures for periods of up to six hours, as well as with other manufacturers' off-the-shelf pump, filter, and reinfusion cannula facilitate venous drainage. It also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, diagnostic and interventional guidewires, and coaxial micro-introducer kits for use in peripheral diagnostic and interventional procedures. In addition, the company provides abscession drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-access kits offer interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero Microwave Tissue Ablation System includes solero microwave generator and the solero MW applicators. AngioDynamics, Inc. was founded in 1988 and is headquartered in Latham, New York.

AngioDynamics, Inc. ANGO Open AngioDynamics, Inc. in new tab

AngioDynamics, Inc.

Key Metrics

Growth

Estimates

DCF Valuation

DCF Assumptions

DCF Result

Explore Premium Features